A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.
UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients
- Thread starter Educator
- Start date